Last reviewed · How we verify
NCT05852275: O-LIVE
O-LIVE: Impact of a Portuguese Olive Oil in Health Biomarkers
NA trial testing Olive-oil in Adult Healthy Volunteers in 30 participants. Status unknown.
1 March 2023
Quick facts
| Lead sponsor | Universidade Católica Portuguesa |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 1 September 2022 |
| Primary completion | 1 March 2023 |
| Estimated completion | 30 May 2023 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Olive-oil
Conditions studied
- Adult Healthy Volunteers — all drugs for Adult Healthy Volunteers →
Sponsor
Universidade Católica Portuguesa
Who can join
Adults 18 to 55, any sex, with Adult Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research project, approved and funded, is part of a larger project, entitled "Healthy Soil for Food", which completes several work packages, one of which is a clinical research submitted to Ethics Committee entitled "O-LIVE: Impact of olive oil Portuguese in biomarkers of healthy volunteers". The main objective of this work is to evaluate the impact of ingestion of an olive oil rich in polyphenols on clinical biomarkers and parameters, such as anthropometric measurements, on inflammatory gene expression regulation and on the composition of the intestinal microbiota.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Metabolic and Analytical Changes of Healthy Volunteers upon Intake of Portuguese Extra Virgin Olive Oil: A Comparison Study between Pre- and Post-Intervention.
Correia M, Moreira I, El Maghariki J, Manuel T, et al · · 2023 · cited 3× · PMID 37571288 · DOI 10.3390/nu15153351 -
Unraveling the Extra Virgin Olive Oil Effect on Inflammation and on Gut and Saliva Microbiota.
Correia M, Gomes ATPC, Moreira I, El Maghariki J, et al · · 2025 · cited 2× · PMID 40149874 · DOI 10.3390/biom15030338
Verify or expand the search:
- PubMed search for NCT05852275
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universidade Católica Portuguesa trials
Trials by the same sponsor.
- NCT06284720 — Transcranial Alternating Current Stimulation for the Improvement of Episodic Memory in Healthy Older Adults · NA · unknown
- NCT07153874 — The Research Aims to Study the Effectiveness of a Physical Exercise Program on Indicators of Quality of Life and Functio · NA · active not recruiting
- NCT06113484 — Impact of a Mediterranean Diet on Cardiovascular Disease Risk Factors · NA · unknown
- NCT05060055 — Digital Assessment at Peri-implant Tissues After Immediate Implants With Customized Healing Abutments and Connective Tis · NA · completed
- NCT04432519 — Multi-level Dimensional Changes at Immediate Implant Sites · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05852275 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Católica Portuguesa
- Last refreshed: 10 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05852275.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing